FormulaFolio Investments’s Vertex Pharmaceuticals VRTX Stock Holding History

FormulaFolio Investments’s Portfolio VRTX Stock Details VRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	$8K	Hold	40	–	–	﹤0.01%	298
2021 Q1	$9K	Sell	40 -1,310	-97%	-$288K	﹤0.01%	292
2020 Q4	$319K	Buy	1,350 +7	+0.5%	+$1.61K	0.01%	522
2020 Q3	$365K	Buy	1,343 +436	+48%	+$120K	0.01%	230
2020 Q2	$263K	Buy	+907	New	+$246K	0.01%	248
2019 Q4	–	Sell	-3,586	Closed	-$608K	–	390
2019 Q3	$608K	Buy	+3,586	New	+$634K	0.02%	206
2019 Q2	–	Sell	-3,661	Closed	-$674K	–	361
2019 Q1	$674K	Buy	+3,661	New	+$676K	0.03%	164

Other funds holding VRTX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

FormulaFolio Investments's VRTX Position: Q2 2021 in Review

FormulaFolio Investments held its Vertex Pharmaceuticals (VRTX) position steady in Q2 2021 at 40 shares worth $8K. The position accounts for ﹤0.01% of the portfolio, ranked #298.

FormulaFolio Investments first reported a position in VRTX in Q1 2019 and has held it in 7 quarters since. The position peaked at $674K in Q1 2019. 976 funds tracked by Wall St. Rank hold VRTX as of Q2 2021.

FormulaFolio Investments held 40 shares of Vertex Pharmaceuticals worth $8K as of Q2 2021.
FormulaFolio Investments left its Vertex Pharmaceuticals share count unchanged in Q2 2021.
Vertex Pharmaceuticals made up ﹤0.01% of FormulaFolio Investments's portfolio in Q2 2021, its #298 holding.
FormulaFolio Investments first reported a position in Vertex Pharmaceuticals in Q1 2019 and has held it in 7 quarters since.
FormulaFolio Investments's Vertex Pharmaceuticals position peaked at $674K in Q1 2019.
976 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2021.

Based on FormulaFolio Investments's 13F filing for Q2 2021, filed 28 Jul 2021.